Aspire Biopharma Holdings, Inc. Stock Analysis & AI Score
Aspire Biopharma Holdings, Inc. (ASBP) has an ST Score of 45.5 (C+), driven by its Financial Strength (A-) and held back by its Growth (F). ASBP last traded at $8.70.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Aspire Biopharma Holdings, Inc. (ASBP) has an ST Score of 45.5 (C+), driven by its Financial Strength (A-) and held back by its Growth (F). ASBP last traded at $8.70.
- Strongest
- Financial StrengthA-
- Weakest
- GrowthF
All factor grades
- Financial StrengthA-
- MomentumB-
- ValuationC
- ProfitabilityC
- GrowthF
- Piotroski5/9
Contact
ASBP stock: frequently asked questions
What is ASBP's ST Score?
Aspire Biopharma Holdings, Inc. (ASBP) has an ST Score of 45.5 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ASBP a buy, hold, or sell?
Our ST Score grades it C+ (45.5/100). The ST Score is a data-driven signal, not a recommendation.
What are ASBP's factor grades?
Valuation C, Profitability C, Financial Strength A-, Momentum B-, Growth F.
What is ASBP's valuation grade?
Aspire Biopharma Holdings, Inc. (ASBP) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ASBP's growth grade?
Aspire Biopharma Holdings, Inc. (ASBP) earns a growth grade of F, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ASBP's profitability grade?
Aspire Biopharma Holdings, Inc. (ASBP) earns a profitability grade of C, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ASBP's financial strength grade?
Aspire Biopharma Holdings, Inc. (ASBP) earns a financial strength grade of A-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is ASBP's Piotroski score?
Aspire Biopharma Holdings, Inc. (ASBP) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.